Freedom Capital initiated coverage of iRhythm (IRTC) with a Buy rating and $205 price target The company’s Zio Monitor has established itself as a ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $189.21, along with a high estimate of $220.00 and a low estimate of $170.00. Marking an ...

SAN FRANCISCO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the U.S. launch of its next-generation Zio® monitor and enhanced Zio® long-term continuous ...

We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. iRhythm Technologies, Inc. is one ...

SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (IRTC) (NASDAQ:IRTC) today announced the commercial launch in Japan of its Zio ® long-term continuous ECG monitoring (LTCM) ...

iRhythm Technologies Inc's (NASDAQ:IRTC) revenue of $124.1 million increased 21.6% Y/Y, beating the consensus of $120.34 million. The increase was driven by volume growth of Zio services, partially ...

iRhythm Technologies IRTC recently announced initial research findings on the post-market, real-world performance of the Zio monitor, IRTC’s next-generation Zio long-term continuous monitoring (LTCM) ...

Zio ECG monitoring system is the only fourteen-day cardiac monitoring service in its category to receive Japanese regulatory approval as an improved device without a clinical trial Zio long-term ...

Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups. Latest data showed ...

iRhythm Technologies, maker of the Zio patch peel-and-stick heart monitor, has raised $17 million in a round led by Novo A/S, a Danish life sciences investment firm. Previous investor Norwest Venture ...

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired iRhythm ...